Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Icahn School of Medicine at Mount Sinai at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Icahn School of Medicine at Mount Sinai brings 49 presentations to ASH 2026 in New Orleans. Its program spans myelodysplastic and myeloproliferative neoplasms, myeloma, lymphoma and sickle cell disease. It covers topics such as dronabinol for chronic pain in sickle cell disease and myeloma in people exposed to the World Trade Center.

OrganizationASH 2026 Attendance
Universities & research institutes
Medical and graduate school of the Mount Sinai Health System in New York City.
Symposium
Fri Dec 11
7:00am–10:00am
MDS in Practice: Navigating Complex Decisions Across the Disease Spectrum
Managing myelodysplastic neoplasms across their spectrum, from clonal hematopoiesis and lower- and higher-risk disease to overlap syndromes and leukemia.
Leukemias
Symposium
Fri Dec 11
11:00am–2:00pm
A Case-Based Exploration of CAR T-Cell Therapy in Multiple Myeloma – Where We Are, Where We’re Going
Real patient cases showing how experts use approved and investigational CAR-T therapies in multiple myeloma now, and where the treatment is heading.
Myeloma · Cell & gene
Symposium
Fri Dec 11
11:00am–2:00pm
Show Me the Data™: Emerging Evidence and Evolving Clinical Practice in Essential Thrombocythemia and Polycythemia Vera
Newer options for polycythemia vera and essential thrombocythemia, such as ropeginterferon and rusfertide, and what to do when hydroxyurea fails.
Leukemias
Symposium
Fri Dec 11
3:00pm–6:00pm
Cases and Conversations: Applying Emerging Evidence to Real-World Care in Myeloproliferative Neoplasms
Choosing among new myeloproliferative neoplasm drugs, including Janus kinase and telomerase inhibitors, hepcidin mimetics, and calreticulin-targeted antibodies.
Leukemias
Talk
Sat Dec 12
9:30am–10:45am
Modeling Ancestry-Informed Bias in Hematology: Duffy-null Status and Other Genotypic Determinants
How diverse genomic data and new computational methods improve risk prediction across populations, including ancestry effects like Duffy-null neutrophil counts.
Blood biology · Patient care

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Icahn School of Medicine at Mount Sinai

Tell us what you sell and we’ll find the people at Icahn School of Medicine at Mount Sinai most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction